NCT01611116View on ClinicalTrials.gov

Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

April 26, 2017

Study Completion Date

April 26, 2017

Conditions
Acute Myeloblastic Leukemia
Interventions
DRUG

sodium chloride solution 0.9%

intravenous application added to standard chemotherapy on up to 8 predefined days during the course of study treatment

DRUG

temsirolimus

intravenous application added to standard chemotherapy on up to 16 predefined days during the course of study treatment

Trial Locations (5)

10117

Charité University Hospital Berlin, Campus Benjamin Franklin, Berlin

48149

University Hospital Münster, Münster

60590

University Hospital Frankfurt, Frankfurt am Main

91054

University Hospital Erlangen, Erlangen

01307

University Hospital Dresden, Dresden

Sponsors

Lead Sponsor

Goethe University
All Listed Sponsors
lead

Goethe University

OTHER